Naldemedine Improves Patient-Reported Outcomes of Opioid-Induced Constipation in Patients with Chronic Non-Cancer Pain in the COMPOSE Phase 3 Studies
Michael Camilleri(CSIRO Manufacturing), James Wild(Williams (United States)), Lynn R. Webster(Adherent Technologies (United States)), M. Hale, Jan Tack(KU Leuven), Bart Morlion(KU Leuven)
Cited by 14
Related Papers
Functional Gastroduodenal Disorders
|Gastroenterology|2006|2.4k
Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study
|Gastroenterology|2020|2.1k
Predicting Aberrant Behaviors in Opioid-Treated Patients: Preliminary Validation of the Opioid Risk Tool
|Pain Medicine|2005|1.1k
Intestinal barrier function in health and gastrointestinal disease
|Neurogastroenterology & Motility|2012|886
Pneumatic Dilation versus Laparoscopic Heller's Myotomy for Idiopathic Achalasia
|New England Journal of Medicine|2011|852